However, in BV treated lymphocytes, Bcl-2 expression showed non significant downregulation at 24 hr after treatment (0.91 ± 0.03-fold), which was sustained at nearly the same level at 72 hr after BV treatment (0.87 ± 0.07-fold) compared to the control group. The gene discussed is BCL2; the disease is bacterial vaginosis.